BiotechTube
Home/ImmuCell/Michael F. Brigham
MF

Michael F. Brigham

President, CEO and Treasurer

ImmuCell

Therapeutic Areas

MastitisEnteric Disease (Scours)

ImmuCell Pipeline

DrugIndicationPhase
Re-Tain™Subclinical Mastitis in Lactating Dairy CowsFDA Review (NADA)
First Defense®Prevention of Enteric Colibacillosis (Calf Scours)Commercial
Wipe Out® Dairy WipesPre-milking Teat SanitizationCommercial

Leadership Team at ImmuCell

BJ
Bobbi Jo Brockmann
Director of Sales and Marketing
JS
Joseph S. Crabb
Former Chief Scientific Officer and Director (co-founder)
DB
David B. Tomsche
Director (Chairman of the Board)
View full ImmuCell profile